CClinicalTrials.gg
CompletedNCT07046325Updated Jul 1, 2025

Comparison Between Dexametidomedine\Bupivacaine and Plain Bupivacaine in Superior Trunk Block for Arthroscopic Shoulder Surgeries

An interventional study of dexametedomidine and Bupivacain in Post Operative Pain, Acute and Arthroscopic Shoulder Surgery, sponsored by Ain Shams University. Completed at 1 site in Egypt. Open to participants aged 20 Years to 50 Years. Per ClinicalTrials.gov, last updated 2025-07-01.

Sponsored by Ain Shams University · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 4 months after the study started (first participant enrolled Jan 2025, registered Jun 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
20 Years to 50 Years
Sex
All
01

Study summary

Comparison between dexametidomedine\bupivacaine and plain bupivacaine in superior trunk block for arthroscopic shoulder surgeries

Read the detailed description

This study will be conducted to investigate the efficacy of adding dexmedetomidine in STB for postoperative analgesia in patients undergoing arthroscopic shoulder surgery.

  • Inclusion Criteria:

    1. age ;20-50 years old of both genders
    2. American Society of Anesthesiologists physical status I and II
    3. BMI less than 30
    4. Arthroscopic shoulder surgeries.
  • Exclusion Criteria:

    1. Patients with ASA more than II
    2. Patients with a sepsis, malignancy anywhere
    3. Patient with bleeding tendencies or on anticoagulation therapy
    4. Patients with pre-existing neurologic deficit or neuropathy affecting brachial plexus
    5. Allergy to study drugs.

Study groups:

The patients will be randomized into 2 groups:

  1. Group DB: are administered Ultrasound guided STB with bupivacaine and dexametidomedine.
  2. Group B: are administered Ultrasound guided STB with bupivacaine.

Primary outcome:

Duration of analgesia of Superior trunck block.

Secondary outcome:

  1. Cumulative dose of postoperative consumption of the rescue analgesia during 24h after STB
  2. Durations of motor blockade (DOM)
  3. Residual block related neurological symptoms
  4. Hemodynamic variables
  5. Dyspnea and sedation scale.
02

Conditions studied

  • Post Operative Pain, Acute
  • Arthroscopic Shoulder Surgery

Browse trials for

03

In context

Pain, Postoperative

5,093 studies on the registry are indexed under Pain, Postoperative; 1,140 are open to participants now.

This study's enrollment of 40 is below the median of 75 across 4,344 interventional studies indexed under Pain, Postoperative.

Browse Pain, Postoperative studies →

Lead sponsor

Ain Shams University is the lead sponsor of 1,876 studies on the registry; 423 are open to participants now.

Of its 32 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age ;20-50 years old
  • Both genders
  • American Society of Anesthesiologists physical status I and II
  • BMI less than 30
  • Arthroscopic shoulder surgeries.

Exclusion criteria

Exclusion Criteria:

  • Patients with ASA more than II
  • Patients with a sepsis, malignancy anywhere
  • Patient with bleeding tendencies or on anticoagulation therapy
  • Patients with pre-existing neurologic deficit or neuropathy affecting brachial plexus
  • Allergy to study drugs.
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
40 participants (actual)

Study arms

  • Active comparator
    group B

    group administered Ultrasound guided STB with bupivacaine

    Drug: Bupivacain

  • Active comparator
    group DB

    group administered Ultrasound guided STB with bupivacaine and dexametidomedine.

    Drug: dexametedomidine · Drug: Bupivacain

Interventions

  • Drugdexametedomidine

    1\. Group DB: are administered Ultrasound guided STB with bupivacaine and dexametidomedine.

  • DrugBupivacain

    2\. Group B: are administered Ultrasound guided STB with bupivacaine.

06

What researchers measure

Primary outcomes

  1. Duration of analgesia of Superior trunck block.

    The DOA will be defined as the time interval between STB and the first need for the rescue analgesics.

    Time frame: 24 hours

07

Study locations

1 site
  • Ain Shams University
    Cairo, Egypt 00202, Egypt
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 1, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07046325
Lead sponsor
Ain Shams University
Responsible party
Sponsor
First posted
Jul 1, 2025
Start date
Jan 20, 2025
Primary completion
Apr 20, 2025
Completion
May 1, 2025
Last update
Jul 1, 2025

Study contacts

fagr fathy abdo, Medical Doctorate
principal investigator · Ain Shams University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion